We are live on
!
Find out more
BL
Bleichroeder LP Portfolio holdings
AUM
$559M
Turnover
17.24%
1-Year Est. Return
83.7%
This Fund
S&P 500
This Quarter
Est. Return
-6.55%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$616M
AUM Growth
-$47.1M
(-7.1%)
Cap. Flow
+$2.74M
Cap. Flow
% of AUM
0.45%
Top 10 Holdings %
Top 10 Hldgs %
61.13%
Holding
110
New
18
Increased
5
Reduced
1
Closed
13
Avg Time Held
0.9
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$35.6M |
| 2 |
Cue Health Inc. Common Stock
HLTH
|
+$15.8M |
| 3 |
CORS
Corsair Partnering Corporation
CORS
|
+$12.2M |
| 4 |
TLMD
SOC Telemed, Inc. Class A Common Stock
TLMD
|
+$7.96M |
| 5 |
Sonos
SONO
|
+$5.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Filana Therapeutics
FLNA
|
+$32M |
| 2 |
GRA
W.R. Grace & Co.
GRA
|
+$13.9M |
| 3 |
SHLX
Shell Midstream Partners, L.P.
SHLX
|
+$13.5M |
| 4 |
Optimum Communications Inc
OPTU
|
+$10.2M |
| 5 |
Fate Therapeutics
FATE
|
+$8.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.29% |
| 2 | Financials | 14.03% |
| 3 | Industrials | 13.51% |
| 4 | Miscellaneous | 13.22% |
| 5 | Consumer Discretionary | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Sprott Physical Gold
PHYS
$14.9B
| $173K | 0.03% |
12,540
| – | – |
2019 Q4
7 quarters
|
|
|
QTEK
77
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
| $149K | 0.02% |
15,000
| – | – |
2021 Q2
1 quarter
|
|
78
Bank of New York Mellon
BNY
$96.4B
| $104K | 0.02% |
2,000
| – | – |
2020 Q1
6 quarters
|
|
79
Alliance Entertainment Holding Corp Warrants
AENTW
| $103K | 0.02% |
200,000
| – | – |
2021 Q2
1 quarter
|
|
80
Cadence Design Systems
CDNS
$89.3B
| $80K | 0.01% |
525
| – | – |
2020 Q2
5 quarters
|
|
|
XLNX
81
DELISTED
Xilinx Inc
XLNX
| $80K | 0.01% |
530
| – | – |
2020 Q2
5 quarters
|
|
82
Teradyne
TER
$53.7B
| $66K | 0.01% |
600
| – | – |
2020 Q2
5 quarters
|
|
83
ExxonMobil
XOM
$718B
| $63K | 0.01% |
1,075
| – | – |
2020 Q2
5 quarters
|
|
|
FAZEW
84
DELISTED
FaZe Holdings Inc. Warrant
FAZEW
| $58K | 0.01% |
75,000
| – | – |
2021 Q2
1 quarter
|
|
85
AbbVie
ABBV
$501B
| $56K | 0.01% |
515
| – | – |
2020 Q2
5 quarters
|
|
86
Lumentum
LITE
$78.8B
| $55K | 0.01% |
660
| – | – |
2020 Q2
5 quarters
|
|
87
Altria Group
MO
$123B
| $55K | 0.01% |
1,200
| – | – |
2020 Q2
5 quarters
|
|
88
Liberty Latin America Class A
LILA
$1.62B
| $53K | 0.01% |
5,913
| – | – |
2020 Q1
6 quarters
|
|
|
BRIVW
89
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
| $53K | 0.01% |
+75,000
| New | +$70K |
2021 Q3
0 quarters
|
|
|
HCARW
90
DELISTED
Healthcare Services Acquisition Corporation Warrant
HCARW
| $50K | 0.01% |
75,000
| – | – |
2021 Q1
2 quarters
|
|
|
SLGCW
91
DELISTED
SomaLogic, Inc. Warrant
SLGCW
| $48K | 0.01% |
14,020
| – | – |
2021 Q2
1 quarter
|
|
92
AT&T
T
$161B
| $45K | 0.01% |
2,185
| – | – |
2020 Q2
5 quarters
|
|
93
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $41K | 0.01% |
+318
| New | +$48.6K |
2021 Q3
0 quarters
|
|
|
QTEKW
94
DELISTED
QualTek Services Inc. Warrant
QTEKW
| $5K | ﹤0.01% |
3,750
| – | – |
2021 Q2
1 quarter
|
|
95
DELISTED
Cazoo Group Ltd Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CZOO.WS
| $4K | ﹤0.01% |
+2,500
| New | +$4.02K |
2021 Q3
0 quarters
|
|
96
Adeia
ADEA
$2.4B
| $2K | ﹤0.01% |
340
| – | – |
2020 Q2
5 quarters
|
|
97
Aviat Networks
AVNW
$250M
| $2K | ﹤0.01% |
66
| – | – |
2020 Q2
5 quarters
|
|
98
Ameriprise Financial
AMP
$44.4B
| – | – |
-15,993
| Closed | -$3.98M | – |
|
|
99
Fate Therapeutics
FATE
$231M
| – | – |
-100,000
| Closed | -$8.68M | – |
|
100
NGL Energy Partners
NGL
$1.85B
| – | – |
-2,112,695
| Closed | -$5.03M | – |
|
Similar funds
NFW
SCM
PHC
EPM
BCM
FAM
WDG
OC
Bleichroeder LP's Q3 2021 Portfolio in Review
As of Q3 2021, Bleichroeder LP held 110 positions worth $616M, down 7.1% from $663M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Bleichroeder LP's Q3 2021 filing shows 18 new, 5 increased, 1 reduced and 13 closed positions. Its largest new stake was Cue Health Inc. Common Stock: 1,000,000 shares worth $11.8M. The largest sale was Filana Therapeutics, an estimated $32M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.
- Bleichroeder LP's largest Q3 2021 buy was Cue Health Inc. Common Stock: 1,000,000 shares worth $11.8M.
- Bleichroeder LP added most to Royalty Pharma in Q3 2021, an estimated $35.6M increase.
- Bleichroeder LP's biggest Q3 2021 reduction was Optimum Communications Inc, cutting an estimated $10.2M.
- Bleichroeder LP fully exited Filana Therapeutics in Q3 2021, selling an estimated $32M.
- Bleichroeder LP's ten largest holdings make up 61% of its $616M portfolio in Q3 2021.
- Bleichroeder LP opened 18 new positions and closed 13 in Q3 2021.
- Bleichroeder LP's portfolio value fell 7.1% quarter-over-quarter to $616M.
Based on Bleichroeder LP's 13F filing for Q3 2021, filed 15 Nov 2021.